# A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

> **NCT00970632** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 511 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia (BPH)

## Interventions

- **DRUG:** Tadalafil 5 mg
- **DRUG:** Placebo tablet
- **DRUG:** Tamsulosin
- **DRUG:** Placebo capsule

## Key facts

- **NCT ID:** NCT00970632
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 511 (ACTUAL)
- **Last updated:** 2012-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00970632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00970632, "A Study of Tadalafil in Men With Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00970632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*